328 related articles for article (PubMed ID: 16723889)
1. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
2. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
[TBL] [Abstract][Full Text] [Related]
3. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
4. Conventional MR imaging with simultaneous measurements of cerebral blood volume and vascular permeability in ganglioglioma.
Law M; Meltzer DE; Wetzel SG; Yang S; Knopp EA; Golfinos J; Johnson G
Magn Reson Imaging; 2004 Jun; 22(5):599-606. PubMed ID: 15172052
[TBL] [Abstract][Full Text] [Related]
5. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
[TBL] [Abstract][Full Text] [Related]
6. [Possibilities of the use of MR tomography-based cerebral blood volume maps in the diagnosis of brain tumors].
Hackländer T; Hofer M; Reichenbach J; Bettag JM; Kiwit JC; Herzog H; Mödder U
Rofo; 1995 Dec; 163(6):484-9. PubMed ID: 8547618
[TBL] [Abstract][Full Text] [Related]
7. Near complete surgical resection predicts a favorable outcome in pediatric patients with nonbrainstem, malignant gliomas: results from a single center in the magnetic resonance imaging era.
Bucci MK; Maity A; Janss AJ; Belasco JB; Fisher MJ; Tochner ZA; Rorke L; Sutton LN; Phillips PC; Shu HK
Cancer; 2004 Aug; 101(4):817-24. PubMed ID: 15305415
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma.
Bakardjiev AI; Barnes PD; Goumnerova LC; Black PM; Scott RM; Pomeroy SL; Billett A; Loeffler JS; Tarbell NJ
Cancer; 1996 Aug; 78(4):864-73. PubMed ID: 8756383
[TBL] [Abstract][Full Text] [Related]
9. A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.
Aprile I; Muti M; Principi M; Bartolini N; Zenoni A; Tazza G; Italiani M; Ottaviano P
Radiol Med; 2002; 104(1-2):87-91. PubMed ID: 12386559
[TBL] [Abstract][Full Text] [Related]
10. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H
Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial radiosurgery of low grade glioma].
Kreth FW; Warnke PC; Ostertag CB
Nervenarzt; 1993 Oct; 64(10):633-9. PubMed ID: 8232676
[TBL] [Abstract][Full Text] [Related]
12. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma].
Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330
[TBL] [Abstract][Full Text] [Related]
14. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors.
Barker FG; Chang SM; Huhn SL; Davis RL; Gutin PH; McDermott MW; Wilson CB; Prados MD
Cancer; 1997 Sep; 80(5):936-41. PubMed ID: 9307194
[TBL] [Abstract][Full Text] [Related]
15. Oligodendrogliomas in the CT/MR-era.
Leonardi MA; Lumenta CB
Acta Neurochir (Wien); 2001 Dec; 143(12):1195-203. PubMed ID: 11810382
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases.
Kremer S; Grand S; Berger F; Hoffmann D; Pasquier B; Rémy C; Benabid AL; Bas JF
Neuroradiology; 2003 Jan; 45(1):44-9. PubMed ID: 12525954
[TBL] [Abstract][Full Text] [Related]
17. T cell adoptive immunotherapy of newly diagnosed gliomas.
Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S
Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis in patients with glioblastoma multiforme: predictive value of choline-to-N-acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume.
Oh J; Henry RG; Pirzkall A; Lu Y; Li X; Catalaa I; Chang S; Dillon WP; Nelson SJ
J Magn Reson Imaging; 2004 May; 19(5):546-54. PubMed ID: 15112303
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy for low-grade gliomas.
Mason WP
Forum (Genova); 2000; 10(2):95-104. PubMed ID: 10875972
[TBL] [Abstract][Full Text] [Related]
20. Oligodendroglioma: does deferring treatment compromise outcome?
Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
